2025-04-11 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Key Figures & Initial Analysis:**

Intuitive Surgical Inc. (ISRG) designs, manufactures, and sells da Vinci surgical systems and related instruments and accessories.  The company's cumulative return significantly outperforms the S&P 500 (VOO).

**1. Performance Comparison:**

* **ISRG Cumulative Return:** 117.93%
* **VOO (S&P 500) Cumulative Return:** 62.76%
* **Return Difference:** 55.17%  (This is the difference in cumulative return as of the last data point provided.)
* **Relative Divergence:** 48.3% (This indicates ISRG's outperformance relative to its historical range of outperformance compared to the S&P 500).


**Alpha and Beta Analysis:**

The provided data shows high CAGR (Compound Annual Growth Rate) for ISRG across most periods, ranging from 47% to 91%.  However, the last two years show negative CAGR, highlighting potential market sensitivity. The Alpha consistently remains positive, indicating outperformance relative to the market benchmark, particularly in recent years.  Beta fluctuates, indicating varying sensitivity to market movements.  Market capitalization (Cap(B)) shows significant growth over the period.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 38.0% | 0.0 | 43.6 |
| 2016-2018  | 77.0% | 63.4% | 60.0% | 0.0 | 57.2 |
| 2017-2019  | 81.0% | 63.4% | 52.0% | 0.3 | 70.6 |
| 2018-2020  | 47.0% | 63.4% | 22.0% | 0.2 | 97.7 |
| 2019-2021  | 91.0% | 63.0% | 37.0% | 0.3 | 128.7 |
| 2020-2022  | -3.0% | 69.9% | -9.0% | 0.3 | 95.0 |
| 2021-2023  | -5.0% | 72.9% | -22.0% | 1.0 | 120.8 |
| 2022-2024  | 26.0% | 72.9% | 9.0% | 1.0 | 186.9 |
| 2023-2025  | 39.0% | 72.9% | 28.0% | 0.7 | 177.1 |


**2. Recent Price Movement:**

* **Closing Price:** $494.43
* **Last Market Price:** $493.17
* **Previous Close:** $522.95
* **Change:** -$5.69 (a significant drop)
* **5-Day Moving Average:** $472.37
* **20-Day Moving Average:** $490.40
* **60-Day Moving Average:** $546.36

The stock price is below all three moving averages, suggesting a potential downtrend.  The recent price drop of $5.69 is significant and needs further investigation.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4271 (Medium Risk)
* **RSI:** 50.72 (Near neutral; neither overbought nor oversold)
* **PPO:** -0.0099 (Slightly negative, suggesting weak momentum)
* **Recent Relative Divergence Change (20-day):** -5.5% (Short-term downtrend)
* **Expected Return:** 41.1% (Significant potential for long-term outperformance compared to the S&P 500). The large price drop from the previous close suggests a potential short-term undervaluation, but this is offset by the long term positive prospects.

The recent price drop ('change' value) reflects a significant negative event and adds to the risk profile. The large negative change might indicate a market correction, a company-specific issue or investor sentiment shift.

**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue      |
|------------|-------|---------------|
| 2024-10-18 | $1.59 | $2.04B        |
| 2024-07-19 | $1.48 | $2.01B        |
| 2024-04-19 | $1.54 | $1.89B        |
| 2023-10-20 | $1.18 | $1.74B        |
| 2024-10-18 | $1.18 | $1.74B        | *(Note: Duplicate entry?)*


Revenue has been relatively stable in the last few quarters, but there is some variation.  EPS is relatively stable but also exhibits fluctuation. Note the duplicate entry in the table requires clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |


Revenue shows a clear upward trend, particularly in the most recent quarter. Profit margins are high and consistently above 65%, indicating strong profitability.


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |

Equity is steadily increasing, indicating strong financial health. ROE (Return on Equity) fluctuates but generally remains within a healthy range.


**6. Overall Analysis:**

ISRG demonstrates a strong long-term growth trajectory, significantly outperforming the S&P 500.  However, recent price action shows a considerable decline, indicating potential short-term risks. While financial fundamentals (high profit margins, growing revenue and equity) remain strong, the recent price drop and the moderately negative technical indicators (PPO, negative relative divergence) suggest a cautious approach. The expected return of 41.1% over the long term is promising, but the recent negative price movement and the need to investigate the reason for the drop before making any investment decisions should be considered. Further investigation into the reasons behind the recent price drop and a deeper dive into the company's specific news and announcements would improve the analysis.  The duplicate data point in the earnings report also needs clarification.
